Filing Flows › GoodRx Holdings (GDRX) › Free cash flow
GoodRx Holdings (GDRX) free cash flow by quarter
GoodRx Holdings' free cash flow was $80.5M in Q2 2026 (second quarter 2026), +652% from Q1 2026. Over the last 7 quarters it ranged from $9.3M (Q1 2025) to $80.5M (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $80.5M | +652% | +64% |
| Q1 2026 | $10.7M | -66% | +15% |
| Q4 2025 | $31.6M | -57% | -29% |
| Q3 2025 | $74.3M | +51% | — |
| Q2 2025 | $49.2M | +431% | — |
| Q1 2025 | $9.3M | -79% | — |
| Q4 2024 | $44.6M | — | — |
Q2 2026 at a glance
GoodRx Holdings, Q2 2026: revenue $200M (-1% year over year), operating margin 11.8%, net earnings $8.5M, operating cash flow $80.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is GoodRx Holdings' free cash flow?
GoodRx Holdings' free cash flow was $80.5M in Q2 2026 (second quarter 2026), +652% from Q1 2026.
How has GoodRx Holdings' free cash flow changed?
Over the last 7 quarters it ranged from $9.3M (Q1 2025) to $80.5M (Q2 2026).